Skip to main content

Table 2 Clinical features of miR-93-3p/105 and miR-301b/181a-3p TNBC patients

From: miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer

  miR-301b/181a-3p miR-93-3p/105
Both low One Both high P Both low One Both high P
Local metastasis     0.086     0.676
 No 209 314 183   173 355 178  
 Yes 143 284 166   157 295 141
Distal metastasis     0.487     0.006*
 No 260 425 259   256 476 212  
 Yes 92 173 90   74 174 107
Grade     0.002*     0.063
 1 25 59 22   32 57 17  
 2 163 221 118   127 264 111
 3 144 289 194   153 296 178
Null 20 29 15   18 33 13
Stage     0.186     0.344
 0 3 4 6   4 3 6  
 1 107 176 104   101 197 89
 2 151 299 168   163 293 162
 3 25 45 30   20 58 22
 4 4 4 2   2 6 2
Null 62 70 39   40 93 38